Fabian Wesołek

Mr. Fabian Wesołek

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FWFabian Wesołek
Fabian Wesołek
ZPZbigniew Putowski
Zbigniew Putowski
WSWiktoria Staniszewska
Wiktoria Staniszewska
RLRobert Latacz
Robert Latacz
Łukasz J. KrzychŁukasz J. Krzych
Łukasz J. Krzych
Background/Objectives: In critically ill patients, achieving a mean arterial pressure (MAP) of 65 mmHg is a recommended resuscitation goal to ensure proper tissue oxygenation. Unfortunately, some patients do not benefit from providing such a value, suggesting that other indices are needed for better hemodynamic assessment. Capillary refill time (CRT) has emerged as an established marker for peripheral perfusion and a therapeutic target in critical illness, but its relationship with other exponents of hypoperfusion during vasopressor support after resuscitation period still warrants further research. This study aimed to investigate whether in critically ill patients after initial resuscitation, CRT would provide information independent of other, readily accessible hemodynamic variables. Methods: Critically ill patients who were mechanically ventilated after the resuscitation period and receiving vasopressors were prospectively studied between December 2022 and June 2023. Vasopressor support was measured using norepinephrine equivalent doses (NEDs). CRT, MAP and NED were assessed simultaneously and analyzed using Spearman’s rank correlation. Results: A total of 92 patients were included and 210 combined MAP-CRT-NED-Lactate records were obtained. There was no correlation between CRT and MAP (R = −0.1, p = 0.14) or lactate (R = 0.11, p = 0.13), but there was a positive weak correlation between CRT and NED (R = 0.25, p = 0.0005). In patients with hypotension, in 83% of cases (15/18), CRT was within normal range, despite different doses of catecholamines. When assessing patients with high catecholamine doses, in 58% cases (11/19), CRT was normal and MAP was usually above 65 mmHg. Conclusions: Capillary refill time provides additional hemodynamic information that is not highly related with the values of mean arterial pressure, lactate level and vasopressor doses. It could be incorporated into routine physical examination in critically ill patients who are beyond initial resuscitation.

Verified
Journal Article
Open access
PDF file
MWMaciej Wybraniec
Maciej Wybraniec
KGKamil Górny
Kamil Górny
KJKamil Jabłoński
Kamil Jabłoński
JJJulia Jung
Julia Jung
CRCyryl Rabcewicz
Cyryl Rabcewicz
Katarzyna Mizia-StecKatarzyna Mizia-Stec
Katarzyna Mizia-Stec
Background: Unlike atrial fibrillation (AF), atrial flutter (AFl) is thought to be relatively refractory to pharmacological cardioversion (PC), but the evidence is scarce. The aim of this study was to evaluate the clinical characteristics and efficacy of the PC of AFl with amiodarone in comparison to AF. Materials and methods: This retrospective study covered 727 patients with urgent consult for AF/AFl in a high-volume emergency department between 2015 and 2018. AFl was diagnosed in 222 (30.5%; median age: 68 (62; 75) years; 65.3% men). In a nested case-control study, 59 control patients with AF, matched in terms of age and sex with 60 AFl patients, were subject to PC with amiodarone. The primary endpoint was return of sinus rhythm confirmed using a 12-lead ECG. Results: The AFl population had a median CHA2DS2-VASc score of 3 (2; 4) and episode duration of 72 h (16; 120). In the AFl cohort, 36% of patients were initially subject to PC, 33.3% to electrical cardioversion (EC) and 40.5% to catheter ablation. In comparison to the AF group, the AFl patients required a longer hospitalization time, had a higher rate of EC (p < 0.001) and less frequent use of PC (p < 0.001) and, lower left ventricular ejection fraction (p < 0.001) and more pronounced cardiovascular risk factors. The efficacy of PC with amiodarone was significantly lower in AFl than AF group (39% vs. 65%, relative risk (RR) 0.60, p = 0.007). Conclusions: AFl patients shared a greater burden of comorbidities than AF patients, while the efficacy of PC in AFl was low. Patients should be initially managed with primary electrical cardioversion.

8 November 2024 in Heart Rhythm O2
Verified
Journal Article
Open access
FWFabian Wesołek
Fabian Wesołek
PSPrzemysław Szyszka
Przemysław Szyszka
MCMałgorzata Cichoń
Małgorzata Cichoń
KMKatarzyna Mizia-Stec
Katarzyna Mizia-Stec
MWMaciej Wybraniec
Maciej Wybraniec
Atrial fibrillation (AF) represents an arrhythmia fraught with significant morbidity, mortality, and financial burden for the health care system. Less attention is given to atrial flutter (AFL), which may occur as a stand-alone arrhythmia or coexist with AF in the same patient. Moreover, it is known that AF frequently develops after AFL ablation. Despite different pathophysiologies of AF and AFL, current guidelines provide identical indications for anticoagulation therapy in both arrhythmias, given the lack of trials in patients with AFL. This study attempts at providing an up-to-date literature review on the thromboembolic risk profile in AFL, focusing on differences between AFL and AF. Echocardiographic studies showed that the presence of spontaneous echocardiographic contrast (SEC) and thrombus are much less prevalent in patients with AFL than in those with AF. Patients with AFL had overall better left atrial appendage (LAA) function and lower coagulation marker levels than did patients with AF. Observational studies showed a significantly lower risk of stroke in patients with AFL than in those with AF. One study found a significantly higher ischemic stroke incidence in the AFL cohort only at CHA2DS2-VASc scores from 5 to 9 than in patients without AF or AFL. These findings imply that the thromboembolic risk inherent in AFL seems lower than that in AF. This should be considered in the context of a high chance of permanent AFL termination after successful cavotricuspid isthmus ablation, in contrast to the chronic clinical nature of AF. Although thromboembolic risk exists in AFL, prospective studies are warranted to establish the true prothrombotic properties of AFL, allowing the reassessment of anticoagulant treatment strategy.

2 July 2025 in Polish Journal of Surgery
Verified
Journal Article
Closed access
MKMagdalena Kwiatkowska
Magdalena Kwiatkowska
DKDominika Krupnik
Dominika Krupnik
FWFabian Wesołek
Fabian Wesołek
AJAgnieszka Jonczyk
Agnieszka Jonczyk
Łukasz J. KrzychŁukasz J. Krzych
Łukasz J. Krzych
Introduction: Refeeding syndrome (RS) is a serious complication of nutritional therapy in critically ill patients, to which patients on surgical wards are particularly vulnerable. It is a potentially life-threatening, complex metabolic disorder that occurs in response to the implementation of overly aggressive, inadequate adaptive patient nutritional therapy, often exacerbated by malnutrition. Moreover, if an appropriate diagnostic and therapeutic process is not undertaken, RS itself becomes the cause of subsequent systemic complications such as respiratory failure, neurological disorders, circulatory failure or seizures. Identified risk factors for RS are mostly modifiable.Aim: The article reviews the literature on the current knowledge and recommendations regarding RS and provides practical recommendations to assist surgeons in effectively diagnosing and managing the syndrome during the perioperative period.Methods: A database query was conducted to identify the most recent information related to the topic of this study.Results: Treatment of RS in critically ill patients undergoing surgery is challenging due to overlapping symptoms of the underlying disease and coexisting severe metabolic disorders. Current guidelines recommend a gradual increase in energy intake and regular monitoring of a patient's metabolic status (especially phosphorus, potassium, and magnesium levels) during nutritional treatment.Conclusions: It is necessary to regularly follow the recommendations of scientific societies, which will take into account the specificity of the treatment of patients in the perioperative period with Refeeding Syndrome in the context of coexisting diseases to improve the quality and safety of care of these patients.